161 related articles for article (PubMed ID: 8840991)
1. Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats.
Kelleher DK; Mattheinsen U; Thews O; Vaupel P
Cancer Res; 1996 Oct; 56(20):4728-34. PubMed ID: 8840991
[TBL] [Abstract][Full Text] [Related]
2. Can erythropoietin improve tumor oxygenation?
Kelleher DK; Thews O; Vaupel P
Strahlenther Onkol; 1998 Dec; 174 Suppl 4():20-3. PubMed ID: 9879343
[TBL] [Abstract][Full Text] [Related]
3. Tumor oxygenation in anemic rats: effects of erythropoietin treatment versus red blood cell transfusion.
Kelleher DK; Matthiensen U; Thews O; Vaupel P
Acta Oncol; 1995; 34(3):379-84. PubMed ID: 7779426
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors.
Thews O; Kelleher DK; Vaupel P
Cancer Res; 2001 Feb; 61(4):1358-61. PubMed ID: 11245434
[TBL] [Abstract][Full Text] [Related]
5. Impact of hemoglobin levels on tumor oxygenation: the higher, the better?
Vaupel P; Mayer A; Höckel M
Strahlenther Onkol; 2006 Feb; 182(2):63-71. PubMed ID: 16447012
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant hematopoietins on blood-loss anemia in mice.
Jones KB; Anderson DW; Longmore GD
Iowa Orthop J; 2005; 25():129-34. PubMed ID: 16089085
[TBL] [Abstract][Full Text] [Related]
7. Impact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiation.
Stüben G; Thews O; Pöttgen C; Knühmann K; Sack H; Stuschke M; Vaupel P
Strahlenther Onkol; 2003 Sep; 179(9):620-5. PubMed ID: 14628128
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
[TBL] [Abstract][Full Text] [Related]
9. Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia.
Landgraf H; Grützmacher P; Garcia-Bartels C; Bergmann M; Ehrly AM; Schoeppe W
Eur J Med; 1993; 2(7):393-7. PubMed ID: 8258026
[TBL] [Abstract][Full Text] [Related]
10. rHuEPO and improved treatment outcomes: potential modes of action.
Blackwell K; Gascón P; Sigounas G; Jolliffe L
Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
[TBL] [Abstract][Full Text] [Related]
11. Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study.
Daneryd P; Svanberg E; Körner U; Lindholm E; Sandström R; Brevinge H; Pettersson C; Bosaeus I; Lundholm K
Cancer Res; 1998 Dec; 58(23):5374-9. PubMed ID: 9850068
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats.
Wu H; Ren B; Zhu J; Dong G; Xu B; Wang C; Zheng X; Jing H
Eur J Cardiothorac Surg; 2006 Jun; 29(6):902-7. PubMed ID: 16675226
[TBL] [Abstract][Full Text] [Related]
13. Effect of local hyperthermia on blood flow and microenvironment: a review.
Song CW
Cancer Res; 1984 Oct; 44(10 Suppl):4721s-4730s. PubMed ID: 6467226
[TBL] [Abstract][Full Text] [Related]
14. rHuEPO and treatment outcomes: the preclinical experience.
Ludwig H
Oncologist; 2004; 9 Suppl 5():48-54. PubMed ID: 15591422
[TBL] [Abstract][Full Text] [Related]
15. Human recombinant erythropoietin significantly improves tumor oxygenation independent of its effects on hemoglobin.
Blackwell KL; Kirkpatrick JP; Snyder SA; Broadwater G; Farrell F; Jolliffe L; Brizel DM; Dewhirst MW
Cancer Res; 2003 Oct; 63(19):6162-5. PubMed ID: 14559797
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
[TBL] [Abstract][Full Text] [Related]
17. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs.
Randolph JF; Stokol T; Scarlett JM; MacLeod JN
Am J Vet Res; 1999 May; 60(5):636-42. PubMed ID: 10328437
[TBL] [Abstract][Full Text] [Related]
18. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
[TBL] [Abstract][Full Text] [Related]
19. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.
Pinel S; Barberi-Heyob M; Cohen-Jonathan E; Merlin JL; Delmas C; Plenat F; Chastagner P
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):250-9. PubMed ID: 15093922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
